Approximately 90%of persons living with dementia experience behavioral symptoms, including frontal lobe features involving motivation, planning, social behavior, language, personality, mood, swallowing, and gait.
Objective:
We conducted a two-stage study with a development sample (n = 586) and validation sample (n = 274) to evaluate a brief informant-rated measure of non-cognitive features of frontal lobe dysfunction: the Frontal Behavioral Battery (FBB).
Methods:
In the development sample, internal consistency, principal factor analysis, and correlations between the FBB and outcomes were evaluated. In the validation sample, we examined (a) FBB scores by diagnosis, (b) known-group validity by demographics, subjective complaints, and dementia staging, and (c) correlation between FBB and MRI volumes. Receiver operator characteristic curves assessed the ability of the FBB to discriminate individuals with frontal lobe features due to a neurodegenerative disease.
Results:
The FBB characterized 11 distinct frontal lobe features. Individuals with dementia with Lewy bodies and frontotemporal degeneration had the greatest number of frontal lobe features. Premorbid personality traits of extroversion, agreeableness, and openness were associated with fewer frontal lobe behavioral symptoms, while subjective cognitive complaints were associated with greater symptoms. The FBB provided very good discrimination between individuals with and without cognitive impairment (diagnostic odds ratio: 13.1) and between individuals with and without prominent frontal lobe symptoms (diagnostic odds ratio: 84.8).
Conclusion:
The FBB may serve as an effective and efficient method to assess the presence of non-cognitive symptoms associated with frontal lobe dysfunction, but in a brief fashion that could facilitate its use in clinical care and research.
KhanS, MihailidisA, TaatiB, MihailidisA (2018) Detecting agitation and aggression in people with dementia using sensors-A systematic review. Alzheimers Dement14, 824–832.
4.
HolstA, SkärL (2017) Formal caregivers’ experiences of aggressive behaviour in older people living with dementia in nursing homes: A systematic review. Int J Older People Nurs12, 1–12.
5.
GalynkerII, RoaneDM, MinerC, FeinbergTE, WattsP (1995) Negative symptoms in patients with Alzheimer’s disease. Am J Geriatr Psychiatry3, 52–59.
6.
Kotynia-EnglishR, McGowanH, AlmeidaOP (2005) A randomized trial of early psychiatric intervention in residential care: Impact on health outcomes. Int Psychogeratr17, 475–485.
7.
GalvinJE, ToleaMI, RosenfeldA, ChrisphonteS (2020) The Quick Physical Activity Rating (QPAR) scale: A brief assessment of physical activity in older adults with and without cognitive impairment. PLoS One15, e0241641.
8.
RigbyT, JohnsonDK, TaylorA, GalvinJE (2021) Comon of the caregiving experience of grief, burden, and quality of life in dementia with Lewy bodies, Alzheimer’s disease, and Parkinson’s disease dementia. J Alzheimers Dis80, 421–432.
9.
GerlachL, KalesH (2020) Managing behavioral and psychological symptoms of dementia. Clin Geriatr Med36, 315–327.
10.
PirauL, LuiF (2020) Frontal lobe syndrome. In StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL).
GraftonST, VolzLJ (2019) From ideas to action: The prefrontal-premotor connections that shape motor behavior. Handb Clin Neurol163, 237–255.
13.
BlahakC, BaeznerH, PantoniL, PoggesiA, ChabriatH, ErkinjunttiT, PazekasF, FerroJM, LanghorneP, O’BrienJ, VisserMC, WahlundLO, WaldemarG, WallinA, InzitariD, HennericiMG (2009) Deep frontal and periventricular age-related white matter changes but not basal ganglia and infratentorial hyperintensities are associated with falls: Cross sectional results from the LADIS study. J Neurol Neurosurg Psychiatry80, 608–613.
14.
YangFPG, BalSS, LeeJ-F, ChenC-C (2021) White matter differences in networks in elders with mild cognitive impairment and Alzheimer’s disease. Brain Connect11, 180–188.
15.
VelliganDI, RitchJL, SuiD, DiCoccoM, HuntzingerCD (2002) Frontal Systems Behavior Scale in schizophrenia: Relationships with psychiatric symptomatology, cognition and adaptive function. Psychiatry Res113, 227–236.
16.
GraceJ, MalloyPF (2002) Frontal Systems Behavior Scale. Brown University, Providence, RI.
17.
RoyallDR, MahurinRK, GrayKF (1992) Bedside assessment of executive cognitive impairment: The executive interview. J Am Geriatr Soc40, 1221–1226.
18.
DuboisB, SlachevskyA, LitvanI, PillonB (2000) The FAB: A Frontal Assessment Battery at bedside. Neurology55, 1621–1626.
19.
LeslieFV, FoxeD, DavesonN, FlannaganE, HodgesJR, PiguetO (2016) FRONTIER Executive Screen: A brief executive battery to differentiate frontotemporal dementia and Alzheimer’s disease. J Neurol Neurosurg Psychiatry87, 831–835.
20.
GraceJ, StoutJC, MalloyPF (1999) Assessing frontal lobe behavioral syndromes with the Frontal Systems Behavior Scale. Assessment6, 269–284.
21.
KerteszA, NadkarniN, DavidsonW, ThomasAW (2000) The Frontal Behavioral Inventory in the differential diagnosis of frontotemporal dementia. J Int Neuropsychol Soc6, 460–468.
22.
CummingsJ, MegaM, GrayK, Rosenberg-ThompsonS, CarusiDA, GornbeinJ (1994) The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia. Neurology44, 2308–2314.
23.
KauferD, CummingsJ, KetchelP, SmithV, MacMillanA, ShelleyT, LopezOL, DeKoskyST (2000) Validation of the NPI-Q a brief clinical form of the Neuropsychiatric Inventory. J Neuropsychiatry Clin Neurosci12, 233–239.
GalvinJE, HowardDH, DennySS, DickinsonS, TattonN (2017) The social and economic burden of frontotemporal degeneration. Neurology89, 2049–2056.
26.
BesserLM, GalvinJE (2019) Perceived burden among caregivers of patients with frontotemporal degeneration. Int Psychogeriatr31, 1191–1201.
27.
BesserL, GalvinJE (2020) Diagnostic Experience reported by caregivers of patients with frontotemporal degeneration. Neurol Clin Pract10, 298–306.
28.
BeeklyDL, RamosEM, LeeWW, DeitrichWD, JackaME, WuJ, HubbardJL, KoepsellTD, MorrisJC, KukullWA, NIA Alzheimer’s Disease Centers (2007) The National Alzheimer’s Coordinating Center (NACC) database: The Uniform Data Set. Alzheimer Dis Assoc Disord21, 249–258.
29.
WeintraubS, BesserL, DodgeHH, TeylanM, FerrisS, GoldsteinFC, GiordaniB, KramerJ, LoewensteinD, MarsonD, MungasD, SalmonD, Welsh-BohmerK, ZhouXH, ShirkSD, AtriA, KukullWA, PhelpsC, MorrisJC (2018) Version 3 of the Alzheimer Disease Centers’ Neuropsychological Test Battery in the Uniform Data Set (UDS). Alzheimer Dis Assoc Disord32, 10–17.
30.
GalvinJE, ValoisL, ZweigY (2014) Collaborative transdisciplinary team approach for dementia care. Neurodegener Dis Manag4, 455–469.
31.
GalvinJE (2015) The Quick Dementia Rating System (QDRS): A rapid dementia staging tool. Alzheimers Dement (Amst)1, 249–259.
32.
MorrisJC (1993) The Clinical Dementia Rating (CDR): Current version and scoring rules. Neurology43, 2412–2414.
33.
Gamst-KlaussenT, ChenG, LamuAN, OlsenJA (2016) Health state utility instruments compared: Inquiring into nonlinearity across EQ-5D-5L, SF-6D, HUI-3 and 15D. Qual Life Res25, 1667–1678.
34.
TappenRM, RosselliM, EngstromG (2010) Evaluation of the Functional Activities Questionnaire (FAQ) in cognitive screening across four American ethnic groups. Clin Neuropsychol24, 646–661.
35.
ZaritSH, ToddPA, ZaritJM (1987) Subjective burdens of husbands and wives as caregivers: A longitudinal study. Alzheimer Dis Assoc Disord1, 109–110.
36.
CharlsonME, PompeiP, AlesKL, MacKenzieCR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis40, 373–383.
37.
WilkinsCH, RoeCM, MorrisJC (2010) A brief clinical tool to assess physical function: The mini-physical performance test. Arch Gerontol Geriatr50, 96–100.
38.
FriedLP, TangenCM, WalstonJ, NewmanAB, HirschC, GottdienerJ, SeemanT, TracyR, KopWJ, BurkeG, McBurnieMA; Cardiovascular Health Study Collaborative Research Group (2001) Frailty in older adults: Evidence for a phenotype. J Gerontol A Biol Sci Med Sci56, M146–156.
39.
RosenWG, TerryRD, FuldPA, KatzmanR, PeckA (1980) Pathological verification of ischemic score in differentiation of dementias. Ann Neurol7, 486–488.
40.
ReisbergB (2007) Global measures: Utility in defining and measuring treatment response in dementia. Int Psychogeriatr19, 421–456.
41.
GoslingSD, RentfrowPJ, SwannWBJr (2003) A very brief measure of the big five personality domains. J Res Personal37, 504–528.
42.
CostaPTJr, McCraeRR (1992) Revised NEO Personality Inventory (NEO-PI-R) and NEO Five Factor Inventory (NEO-FFI) professional manual. Psychological Assessment Resources, Odessa, FL.
43.
GalvinJE, ToleaMI, ChrisphonteS (2020) Using a patient-reported outcome to improve detection of cognitive impairment and dementia: The patient version of the quick dementia rating system (QDRS). PLoS One15, e0240422.
44.
NasreddineZS, PhillipsNA, BédirianV, CharbonneauS, WhiteheadV, CollinI, CummingsJL, ChertkowH (2005) The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment. J Am Geriatr Soc53, 695–699.
45.
ShapiroAM, BenedictRH, SchretlenD, BrandtJ (1999) Construct and concurrent validity of the Hopkins Verbal Learning Test-revised. Clin Neuropsychol13, 348–358.
46.
ReitanRM (1958) Validity of the trail making test as an indication of organic brain damage. Perceptual Motor Skills8, 271–276.
47.
GalvinJE, ToleaMI, MooreC, ChrisphonteS (2020) The Number Symbol Coding Task: A brief measure of executive function to detect dementia and cognitive impairment. PLoS One15, e0242233.
48.
SnaithRP (2003) The Hospital Anxiety and Depression Scale. Health Qual Life Outcomes1, 29.
49.
AlbertMS, DeKoskyST, DicksonD, DuboisB, FeldmanHH, FoxNC, GamstA, HoltzmanDM, JagustWJ, PetersenRC, SnyderPJ, CarrilloMC, ThiesB, PhelpsCH (2011) The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging–Alzheimer’s association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement7, 270–279.
50.
McKhannGM, KnopmanDS, ChertkowH, HymanBT, JackCRJr, KawasCH, KlunkWE, KoroshetzWJ, ManyJF, MayeuxR, MohsRC, MorrisJC, RossorMN, ScheltensP, CarrilloMC, ThiesB, WeintraubS, PhelpsCH (2011) The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging–Alzheimer’s association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement7, 263–269.
KroenkeK, SpitzerRL, WilliamsJB, LöweB (2009) An ultra-brief screening scale for anxiety and depression: The PHQ-4. Psychosomatics50, 613–621.
54.
GalvinJE, ToleaMI, ChrisphonteS (2020) The positive and negative appraisals of caregiving (PANAC) scale: A new measure to examine the caregiving experience in Alzheimer’s disease and related dementias. Alzheimer Dement (N Y)6, e12104.
55.
RossDE, OchsAL, TateDF, TokacU, SeabaughJ, AbildskovTJ, BiglerED (2018) High correlations between MRI brain volume measurements based on NeuroQuant(®) and FreeSurfer. Psychiatry Res Neuroimaging278, 69–76.
56.
PerssonK, BarcaML, CavallinL, BrækhusA, KnapskogAB, SelbækG, EngedalK (2018) Comparison of automated volumetry of the hippocampus using NeuroQuant® and visual assessment of the medial temporal lobe in Alzheimer’s disease. Acta Radiol59, 997–1001.
57.
HeisterD, BrewerJB, MagdaS, BlennowK, McEvoyLK (2011) Predicting MCI outcome with clinically available MRI and CSF biomarkers. Neurology77, 1619–1628.
58.
MessickS (1995) Standards of validity and the validity of standards in performance assessment. Educ Measure Issues Pract14, 5–8.
59.
GalvinJE, FaganAM, HoltzmanDM, MintunMA, MorrisJC (2010) Relationship of dementia screening tests with biomarkers of Alzheimer’s disease. Brain133, 3290–3300.
60.
McGeeS (2002) Simplifying likelihood ratios. J Gen Intern Med17, 646–649.
61.
GlasAS, LijmerJG, PrinsMH, BonselGJ, BossuytPM (2003) The diagnostic odds ratio: A single indicator of test performance. J Clin Epidemiol56, 1129–1135.
62.
HarrellF, CaliffR, PryorD, LeeK, RosatiR (1982) Evaluating the yield of medical tests. JAMA247, 2543–2546.
63.
DonnellanMB, LucasRE (2008) Age differences in the Big Five across the life span: Evidence from two national samples. Psychol Aging23, 558–566.
64.
AschwandenD, StrickhouserJE, LuchettiM, StephanY, SutinAR, TerraccianoA (2021) Is personality associated with dementia risk? A meta-analytic investigation. Ageing Res Rev67, 101269.
DongJW, JelescuIO, Ades-AronB, NovikovDS, FriedmanKP, OsorioRS, GalvinJE, SherpherdTM, FieremansE (2020) Diffusion MRI biomarkers of white matter microstructure vary nonmonotonically with increasing cerebral amyloid deposition. Neurobiol Aging89, 118–128.
67.
ReisbergB, BorensteinJ, SalobS, FerrisSH, FranssenE, GeorgotasA (1987) Behavioral symptoms in Alzheimer’s disease: Phenomenology and treatment. J Clin Psychiatry48(Supp 5), 9–15.
68.
AlexopoulosG, AbramsR, YoungR, ShamoianCA (1988) Cornell scale for depression in dementia. Biol Psychiatry23, 271–284.
69.
SinhaD, ZemlanF, NelsonS, BienenfeldD, ThienhausO, RamaswamyG, HamiltonS (1992) A new scale for assessing behavioral agitation in dementia. Psychiatry Res41, 73–88.
70.
HsiehS, ChenC, HuangL, ChangeYH, YangYH (2020) Gender differences in presentation of behavioral and psychological symptoms in Alzheimer’s disease in Taiwan. Aging Ment Health24, 1342–1347.
71.
RiedelO, KlotscheJ, PisaF (2019) Psychiatric symptoms in patients with dementia: Do caregivers and doctors see the same thing?Alzheimer Dis Assoc Disord33, 233–239.
72.
BandyopadhyayT, BiswasA, RoyA, GuisDS, GangopadhyayG, SarkhelS, GhoshalMK, SenaptiAK (2014) Neuropsychiatric profiles in patients with Alzheimer’s disease and vascular dementia. Ann Indian Acad Neurol17, 325–330.
73.
Manso-CalderónR, Cacabelos-PérezP, Sevillano-GarcíaM, Herrero-PrietoME, Gonzalez-SarmientoR (2020) The impact of vascular burden on behavioural and psychological symptoms in older adults with dementia: The BEVASDE study. Neurol Sci41, 165–174.
74.
D’AnnaL, MesulamMM, Thiebaut de SchottenM, Dell’AcquaF, MurphyD, WienekeC, MartersteckA, CobiaD, RogalskiE, CataniM (2016) Frontotemporal networks and behavioral symptoms in primary progressive aphasia. Neurology86, 1393–1399.
75.
MillerBL, CummingsJL (2017) The human frontal lobes: An introduction. In The Human Frontal Lobes: Functions and Disorders, 3rd Ed., Miller BL, Cummings JL, eds. Guilford Press, New York, NY, pp. 1–13.
76.
MoreiraHS, CostaAS, CastroSL, LimaCF, VicenteSG (2017) Assessing executive dysfunction in neurodegenerative disorders: A critical review of brief neuropsychological tools. Front Aging Neurosci9, 369.
77.
PaulsenJS, StoutJC, DeLaPenaJ, RomeroR, TwafikReedyZ, SwensonMR, GraceJ, MalloyPF (1996) Frontal behavioral syndromes in cortical and subcortical dementia. Assessment3, 327–337.
78.
SuhonenNM, HallikainenI, HänninenT, JokelainenJ, KrügerJ, HallA, PikkarainenM, SoininenH, RemesAM (2017) The Modified Frontal Behavioral Inventory (FBI-mod) for patients with frontotemporal lobar degeneration, Alzheimer’s disease, and mild cognitive impairment. J Alzheimers Dis56, 1241–1251.
79.
MilanG, LamenzaF, IavaroneA, GaleoneF, LorèE, de FalcoC, SorrentinoP, PostiglioneA (2008) Frontal Behavioural Inventory in the differential diagnosis of dementia. Acta Neurol Scand117, 260–265.
80.
MichouE, HamdyS (2009) Cortical input in control of swallowing. Curr Opin Otolaryngol Head Neck Surg17, 166–171.
81.
LeopoldNA, DanielsSK (2010) Supranuclear control of swallowing. Dysphagia25, 250–257.
82.
HumbertIA, McLarenDG, KosmatkaK, FitzgeraldM, JohnsonS, PorcaroE, KaysS, UmohEO, RobbinsJ (2010) Early deficits in cortical control of swallowing in Alzheimer’s disease. J Alzheimers Dis19, 1185–1197.
83.
de Melo CoelhoFG, StellaF, de AndradeLP, BarbieriFB, Santos-GaldurózRF, GobbiS, Riani CostaJL, Bucken GobbiLT (2012) Gait and risk of falls associated with frontal cognitive functions at different stages of Alzheimer’s disease. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn19, 644–656.
